SSG
ICPT

Summit Securities Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Summit Securities Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-300
Closed -$13K – 577
2013
Q2 		$13K Buy
+300
New +$10.2K 0.01% 289

Summit Securities Group's ICPT Position: Q3 2013 in Review

Summit Securities Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2013, closing a stake of 300 shares — an estimated $13K sold.

Summit Securities Group first reported a position in ICPT in Q2 2013 and held it in 1 quarter. The position peaked at $13K in Q2 2013. 72 funds tracked by Wall St. Rank hold ICPT as of Q3 2013.

  • Summit Securities Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2013 after selling out during the quarter.
  • Summit Securities Group sold 300 Intercept Pharmaceuticals, Inc. shares in Q3 2013, an estimated $13K.
  • Summit Securities Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 1 quarter.
  • Summit Securities Group's Intercept Pharmaceuticals, Inc. position peaked at $13K in Q2 2013.
  • 72 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2013.

Based on Summit Securities Group's 13F filing for Q3 2013, filed 1 Nov 2013.